Video

Dr. Alexander Kretschmer on next steps for ExoDx Prostate test

Dr. Alexander Kretschmer, MD, discusses the next steps with research and clinical use of the ExoDx Prostate test (EPI test). The non-invasive, urine-based genomic test is a risk assessment tool that helps physicians and patients determine whether a prostate biopsy is necessary when PSA screening provides an ambiguous result

Kretschmer is an assistant professor of Urology at Ludwig-Maximilians-University Munich.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Videos
Ruben Olivares, MD, answers a question during a Zoom video interview
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Bashir Al Hussein Al Awamlh, MD, MPH, answers a question during a Zoom video interview
Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
© 2025 MJH Life Sciences

All rights reserved.